Skip to main content
. 2007 Jan 23;96(2):391–398. doi: 10.1038/sj.bjc.6603432

Table 4. Proportion of patients who require assessment by tumour site and probability.

Tumour type Proportion of new cancers in Australia Role for genetics High % High and moderate % Moderate % Low % Research %
Colorectal 14 Yes 5 21 16 79  
Breast 13 Yes 3 24 21 76  
Ovary 1 Yes 5 5 0 95  
Gynae-ovary 4 Yes 0 3 3 97  
Kidney 3 Yes 0 5 5 95  
Brain 2 Yes 2 2 0 100  
Sarcoma 1 Yes 1 1 0 99  
Thyroid 1 Yes 1 5 4 95  
Lung 10 No 0 0 0 100  
Prostate 12 Yes 0 0 7 93 7
Melanoma 11 Yes 0 0 1 99 1
Head and neck 4 No 0 0 0 100  
Lymphoma 4 No 0 0 0 100  
UK primary 4 No 0 0 0 100  
Bladder 3 No 0 0 0 100  
Leukaemia 3 No 0 0 0 100  
Gastric 2 No 0 0 0 100  
Pancreas 2 No 0 0 0 100  
Liver 1 No 0 0 0 100  
Oesophagus 1 No 0 0 0 100  
Gallbladder 1 No 0 0 0 100  
Myeloma 1 No 0 0 0 100  
Testes 1 No 0 0 0 100  
Other 1 No 0 0 0 100